Decreased in vitro thrombin generation and clot stability in human FXII-null blood and plasma.

Department of Paediatrics, Division of Haematology/Oncology, The Hospital for Sick Children, and University of Toronto Program in Cell Biology, Research Institute of The Hospital for Sick Children, Toronto, ON, Canada Department of Haematology, Mercy University Hospital, Cork, Ireland.
E-mail: .
British Journal of Haematology (Impact Factor: 4.94). 09/2010; 152(1):111-2. DOI: 10.1111/j.1365-2141.2010.08382.x
Source: PubMed
1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The contact system is a plasma protease cascade that is initiated by coagulation factor XII activation on cardiovascular cells. The system starts procoagulant and proinflammatory reactions, via the intrinsic pathway of coagulation or the kallikrein-kinin system, respectively. The biochemistry of the contact system in vitro is well understood, however, its in vivo functions are just beginning to emerge. Data obtained in genetically engineered mice have revealed an essential function of the contact system for thrombus formation. Severe deficiency in contact system proteases impairs thrombus formation but does not reduce the hemostatic capacity of affected individuals. The system is activated by an inorganic polymer, polyphosphate that is released from activated platelets. Excessive inherited activation of the contact system causes a life-threatening swelling disorder, hereditary angioedema. Activation of the contact system by pathogens contributes to leakage in bacterial infections. Mast-cell-derived heparin triggers contact-system-mediated edema formation with implications for allergic disease states. Here we present an overview about the plasma contact system in occlusive and inflammatory disease and its contribution to health and pathology.
    Seminars in Immunopathology 08/2011; 34(1):31-41. · 5.38 Impact Factor

Full-text (2 Sources)

Available from
Dec 11, 2014